share_log

Candel Therapeutics(CADL.US) Director Buys US$7.5 Million in Common Stock

Moomoo News ·  05:15

$Candel Therapeutics (CADL.US)$ Director Manning Paul B purchased 1.25 million shares of common stock on Dec 16, 2024 at an average price of $6 for a total value of $7.5 million.

1734556557303286265.png

What is statement of changes in beneficial ownership of securities?

It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment